摘要
肝脏是公认的结直肠癌最普遍的转移器官,根治性切除术被认为是唯一可能治愈结直肠癌肝转移的治疗方案。但仅有约20%的患者能够接受手术治疗。对于已丧失手术机会的患者,经肝动脉化疗栓塞术(TACE)是被国内外学者广泛采用的首选治疗方案之一。介绍了现阶段临床上TACE治疗结直肠癌肝转移的应用基础、适应证、禁忌证、疗效、化疗药物及栓塞剂等。认为TACE是一种疗效肯定、微创、副反应少的姑息性治疗方案,可以作为不可切除结直肠癌肝转移患者的首选治疗方案。
It is widely acknowledged that the liver is the most common organ for eolorectal cancer metastasis, and radical resection is thought to be the only therapeutic method to cure eolorectal cancer liver metastasis （CRLM）. Unfortunately, only about 20% of all patients are eligible for surgical resection. in patients wbo cannot be treated with surgery, transcatheter arterial chemoembolization （TACE） has been widely used as the preferred therapeutic method by scholars at home and abroad. This article introduces the application basis, indications, eontraindieations, therapeutic effect, chemotherapeutic agents, and embolic agents of TACE in the treatment of CRLM, and points out that TACE is a palliative treatment regimen with a clear therapeutic effect, minimal invasion, and few side effects and can be used as the pre- fen＇ed therapeutic regimen for patients with unreseetable CRLM.
出处
《临床肝胆病杂志》
CAS
2016年第6期1216-1219,共4页
Journal of Clinical Hepatology
关键词
结直肠肿瘤
肿瘤转移
化学栓塞
治疗性
综述
colorectal neoplasm
neoplasm metastasis
chemoembolization, therapeutic
review
